Skip to main content
Top
Published in: Abdominal Radiology 3/2008

01-05-2008

Incidence and imaging appearance of urethrovesical anastomotic urinary leaks following da Vinci robotic prostatectomy

Authors: Todd R. Williams, Oscar J. Longoria, Scott Asselmeier, Mani Menon

Published in: Abdominal Radiology | Issue 3/2008

Login to get access

Abstract

Background

The advent of the da Vinci robotic prostatectomy has several advantages over open and laparoscopic prostatectomy, including fewer complications, better continence and potency. We evaluate the incidence and imaging features of urinary leaks after robotic prostatectomy.

Methods

A retrospective study examining the anastomotic leak rates from 490 consecutive robotic prostatectomy patients. Routine postoperative cystography on day 7 was reviewed for presence and severity of urinary anastomotic leaks.

Results

A total of 490 patients were reviewed, of which 442 had cystographic imaging postoperatively (n = 442). A total of 67 urinary leaks were identified; 40 were small, limited extraperitoneal leaks confined to the surgical bed, 21 were moderate sized leaks limited to the extraperitoneal pelvic space, and six extended in to the peritoneal cavity. Two of these six patients required CT-guided drainage for peritoneal urinoma. Other cystography findings included two cases of vesicoureteral reflux and one case of colovesical fistula.

Conclusion

The incidence of postoperative anastomotic urinary leaks following robotic prostatectomy (13.6%) is the same or better than laparoscopic prostatectomy and traditional radical retropubic prostatectomy. The vast majority of urethrovesical leaks are transient, requiring no follow-up intervention. The incidence of large anastomotic leaks requiring CT guided intervention is exceedingly low 2/490 (<0.5%).
Literature
1.
go back to reference Kaul S, Menon M (2006) Robotic radical prostatectomy: evolution from conventional VIP. World J Urol 24(2):152–160 (Topic paper)PubMedCrossRef Kaul S, Menon M (2006) Robotic radical prostatectomy: evolution from conventional VIP. World J Urol 24(2):152–160 (Topic paper)PubMedCrossRef
2.
go back to reference Rassweiler J, Seeman O, Schulze M, et al. (2003) Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 169(5):1689–1693PubMedCrossRef Rassweiler J, Seeman O, Schulze M, et al. (2003) Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 169(5):1689–1693PubMedCrossRef
3.
go back to reference Bandani K, Hemal A, Peobody J, et al. (2006) Robotic radical prostaectomy: the Vattikuti Urology Institute training experience. World J Urol 24:148–151CrossRef Bandani K, Hemal A, Peobody J, et al. (2006) Robotic radical prostaectomy: the Vattikuti Urology Institute training experience. World J Urol 24:148–151CrossRef
4.
go back to reference Seifert A, Huntington T (2006) Laparoscopic radical prostatectomy in a community hospital without robotic assistance. Urology 68:831–833PubMedCrossRef Seifert A, Huntington T (2006) Laparoscopic radical prostatectomy in a community hospital without robotic assistance. Urology 68:831–833PubMedCrossRef
5.
go back to reference Yablon C, Banner M, Ramchandani P, et al. (2004) Complications of prostate cancer treatment: spectrum on imaging findings. Radiographics 24:181–194CrossRef Yablon C, Banner M, Ramchandani P, et al. (2004) Complications of prostate cancer treatment: spectrum on imaging findings. Radiographics 24:181–194CrossRef
6.
go back to reference Menon M, Hemal A (2006) Robotic urologic surgery: is this the way of the future? World J Urol 24(2):119 (Invited editorial)PubMedCrossRef Menon M, Hemal A (2006) Robotic urologic surgery: is this the way of the future? World J Urol 24(2):119 (Invited editorial)PubMedCrossRef
7.
go back to reference Berlin J, Ramchandani P, Banner M, et al. (1994) Voiding cystourethography after radical prostatectomy. AJR 162:87–91PubMed Berlin J, Ramchandani P, Banner M, et al. (1994) Voiding cystourethography after radical prostatectomy. AJR 162:87–91PubMed
8.
go back to reference Gnanapragasm V, Baker P, Naisby G, et al. (2005) Identification and validation of risk factors for vesicourethral leaks following radical retropubic prostatectomy. Int J Urol 12:948–952CrossRef Gnanapragasm V, Baker P, Naisby G, et al. (2005) Identification and validation of risk factors for vesicourethral leaks following radical retropubic prostatectomy. Int J Urol 12:948–952CrossRef
9.
go back to reference Leibovitch I, Rowland R, Little J, et al. (1995) Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings. Urology 46(1):78–80PubMedCrossRef Leibovitch I, Rowland R, Little J, et al. (1995) Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings. Urology 46(1):78–80PubMedCrossRef
Metadata
Title
Incidence and imaging appearance of urethrovesical anastomotic urinary leaks following da Vinci robotic prostatectomy
Authors
Todd R. Williams
Oscar J. Longoria
Scott Asselmeier
Mani Menon
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9247-8

Other articles of this Issue 3/2008

Abdominal Radiology 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine